Trevi Therapeutics edges higher amid takeover speculation

MSN
2025.12.02 21:45
portai
I'm PortAI, I can summarize articles.

Trevi Therapeutics (TRVI) shares rose 1.2% in after-hours trading due to takeover speculation. Traders mentioned a Betaville "uncooked" alert suggesting potential acquisition interest, though the buyer's identity remains unknown.